171 related articles for article (PubMed ID: 18008365)
1. Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer.
Lo DS; Pollett A; Siu LL; Gallinger S; Burkes RL
Cancer; 2008 Jan; 112(1):50-4. PubMed ID: 18008365
[TBL] [Abstract][Full Text] [Related]
2. The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer.
Kim JC; Lee KH; Yu CS; Kim HC; Kim JR; Chang HM; Kim JH; Kim JS; Kim TW
Eur J Surg Oncol; 2004 Apr; 30(3):271-9. PubMed ID: 15028308
[TBL] [Abstract][Full Text] [Related]
3. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
[TBL] [Abstract][Full Text] [Related]
4. An audit of outcomes in colorectal cancer in China.
Zong XY; Shi YQ
Eur J Surg Oncol; 2007 Mar; 33(2):169-73. PubMed ID: 17097261
[TBL] [Abstract][Full Text] [Related]
5. The mesenteric and antimesenteric site of the tumor as possible prognostic factor in colorectal cancer: 5-year survival analysis.
Boni L; Cantore F; Colombo E; Benevento A; Dionigi G; Rovera F; Capriata G; Dettori G; Dionigi R
Surg Oncol; 2007 Dec; 16 Suppl 1():S79-82. PubMed ID: 18032025
[TBL] [Abstract][Full Text] [Related]
6. The number of analyzed lymph nodes - a prognostic factor in colorectal cancer.
Edler D; Ohrling K; Hallström M; Karlberg M; Ragnhammar P
Acta Oncol; 2007; 46(7):975-81. PubMed ID: 17917828
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
8. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
9. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
[TBL] [Abstract][Full Text] [Related]
10. Defining stage III disease in colorectal cancer--aspects on treatment and evaluation of survival.
Derwinger K; Carlsson G; Ekman T
J Surg Oncol; 2010 Oct; 102(5):424-7. PubMed ID: 20607755
[TBL] [Abstract][Full Text] [Related]
11. Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
Zlobec I; Baker K; Minoo P; Hayashi S; Terracciano L; Lugli A
Cancer; 2009 Sep; 115(17):4021-9. PubMed ID: 19517467
[TBL] [Abstract][Full Text] [Related]
12. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry.
Fietkau R; Zettl H; Klöcking S; Kundt G
Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
[TBL] [Abstract][Full Text] [Related]
14. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma.
Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K
Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299
[TBL] [Abstract][Full Text] [Related]
15. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion.
Strzelczyk B; Szulc A; Rzepko R; Kitowska A; Skokowski J; Szutowicz A; Pawelczyk T
Ann Surg Oncol; 2009 May; 16(5):1287-94. PubMed ID: 19259744
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
17. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.
Tsikitis VL; Larson DL; Wolff BG; Kennedy G; Diehl N; Qin R; Dozois EJ; Cima RR
J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio: role in the staging of node-positive colon cancer.
Wang J; Hassett JM; Dayton MT; Kulaylat MN
Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530
[TBL] [Abstract][Full Text] [Related]
19. Population-based registration of unselected colorectal cancer patients: five-year survival in the region of Bonn/Rhine-Sieg, Germany.
Lamberti C; Di Blasi K; Archut D; Fimmers R; Mathiak M; Bollmann M; Vogel J; Kindermann D; Mezger J; Schmidt-Wolf IG; Sauerbruch T
Z Gastroenterol; 2005 Feb; 43(2):149-54. PubMed ID: 15700204
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and disease outcome of UICC stages I-III colorectal cancer patients at Siriraj Hospital.
Techawathanawanna S; Nimmannit A; Akewanlop C
J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S189-98. PubMed ID: 22574549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
